Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,075 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.
Guttman-Yassky E, Brunner PM, Neumann AU, Khattri S, Pavel AB, Malik K, Singer GK, Baum D, Gilleaudeau P, Sullivan-Whalen M, Rose S, Jim On S, Li X, Fuentes-Duculan J, Estrada Y, Garcet S, Traidl-Hoffmann C, Krueger JG, Lebwohl MG. Guttman-Yassky E, et al. Among authors: rose s. J Am Acad Dermatol. 2018 May;78(5):872-881.e6. doi: 10.1016/j.jaad.2018.01.016. Epub 2018 Jan 17. J Am Acad Dermatol. 2018. PMID: 29353025 Free PMC article. Clinical Trial.
Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial.
Rose S, On SJ, Fuchs W, Chen C, Phelps R, Kornreich D, Haddican M, Singer G, Wong V, Baum D, Vekaria A, Gagliotti M, Huang R, Suárez-Fariñas M, Terry SF, Lebwohl M. Rose S, et al. J Am Acad Dermatol. 2019 Jul;81(1):263-265. doi: 10.1016/j.jaad.2019.02.055. Epub 2019 Feb 28. J Am Acad Dermatol. 2019. PMID: 30826287 Clinical Trial. No abstract available.
Ustekinumab as therapy for psoriasis in a 2-year-old girl.
Min MS, Shroff A, Rose S, Lebwohl M, Guttman-Yassky E. Min MS, et al. Among authors: rose s. J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e109-e110. doi: 10.1111/jdv.13348. Epub 2015 Sep 16. J Eur Acad Dermatol Venereol. 2016. PMID: 26377248 No abstract available.
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.
Brunner PM, Pavel AB, Khattri S, Leonard A, Malik K, Rose S, Jim On S, Vekaria AS, Traidl-Hoffmann C, Singer GK, Baum D, Gilleaudeau P, Sullivan-Whalen M, Fuentes-Duculan J, Li X, Zheng X, Estrada Y, Garcet S, Wen HC, Gonzalez J, Coats I, Cueto I, Neumann AU, Lebwohl MG, Krueger JG, Guttman-Yassky E. Brunner PM, et al. Among authors: rose s. J Allergy Clin Immunol. 2019 Jan;143(1):142-154. doi: 10.1016/j.jaci.2018.07.028. Epub 2018 Aug 17. J Allergy Clin Immunol. 2019. PMID: 30121291 Clinical Trial.
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.
Trager MH, Rizk E, Rose S, Zhu K, Lau B, Fullerton BT, Pradhan J, Moore M, Srivastava AC, Singer G, Gartrell R, Chang R, Geskin LJ, Saenger YM, Goldenberg G. Trager MH, et al. Among authors: rose s. Sci Rep. 2021 Apr 22;11(1):8775. doi: 10.1038/s41598-021-88424-z. Sci Rep. 2021. PMID: 33888854 Free PMC article.
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis.
Gerds AT, Harrison CN, Kiladjian JJ, Mesa R, Vannucchi AM, Komrokji RS, Bose P, Kremyanskaya M, Mead A, Gotlib J, Rose S, Sanabria F, Marsousi N, Giuseppi AC MD, Jiang H, Palmer JM, McCaul K, Ribrag V, Passamonti F. Gerds AT, et al. Among authors: rose s. Blood Adv. 2024 May 31:bloodadvances.2024012939. doi: 10.1182/bloodadvances.2024012939. Online ahead of print. Blood Adv. 2024. PMID: 38820422
3,075 results